Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06419543
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-05-13
Brief Title:
Paradoxical Reactions of Remimazolam in Pediatric Painless Gastrointestinal Endoscopy
Sponsor:
Tongji Hospital
Organization:
Tongji Hospital
Study Overview
Official Title:
Paradoxical Reactions of Remimazolam in Pediatric Painless Gastrointestinal Endoscopy a Prospective Observation Study
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Exploring the effect of remimazolam dose on paradoxical reactions in pediatric painless gastrointestinal endoscopy
Detailed Description:
Exploring the effect of remimazolam dose on paradoxical reactions and sedation in pediatric painless gastrointestinal endoscopy observing the performance and duration of paradoxical reactions and analyze the factors
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None